Cystic fibrosis is a long term genetic condition that affects breathing and digestion. Trikafta treatment has changed the way many patients manage symptoms by helping improve lung function and overall health. Understanding how this treatment works can help patients and families feel more confident about care decisions.
Cystic fibrosis is a genetic disorder that affects the lungs, digestive system, and other organs. Thick mucus buildup can make breathing difficult and increase the risk of infections. Trikafta is a treatment designed to target the underlying cause of cystic fibrosis in eligible patients. It has become an important option for improving quality of life and supporting better long term health outcomes.